These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8949981)

  • 41. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
    Udagawa T; Yuan J; Panigrahy D; Chang YH; Shah J; D'Amato RJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):421-7. PubMed ID: 10900214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
    Jain RK
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelial survival factors as targets for antineoplastic therapy.
    Reinmuth N; Stoeltzing O; Liu W; Ahmad SA; Jung YD; Fan F; Parikh A; Ellis LM
    Cancer J; 2001; 7 Suppl 3():S109-19. PubMed ID: 11779081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenesis in cancer, vascular, rheumatoid and other disease.
    Folkman J
    Nat Med; 1995 Jan; 1(1):27-31. PubMed ID: 7584949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.
    Kato H; Ishikura H; Kawarada Y; Furuya M; Kondo S; Kato H; Yoshiki T
    Jpn J Cancer Res; 2001 Jan; 92(1):67-73. PubMed ID: 11173546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tumor angiogenesis].
    Bussolino F
    Recenti Prog Med; 1999 Jan; 90(1):28-36. PubMed ID: 10193163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiogenesis inhibitors in lung cancer.
    Kim ES; Herbst RS
    Curr Oncol Rep; 2002 Jul; 4(4):325-33. PubMed ID: 12044242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. VEGF receptor signaling in tumor angiogenesis.
    McMahon G
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New drugs to block tumor's blood supply.
    Dickman S
    Ann Oncol; 1996 Nov; 7(9):874-5. PubMed ID: 9006735
    [No Abstract]   [Full Text] [Related]  

  • 50. Endogenous inhibitors of angiogenesis.
    Ruhrberg C
    J Cell Sci; 2001 Sep; 114(Pt 18):3215-6. PubMed ID: 11591810
    [No Abstract]   [Full Text] [Related]  

  • 51. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biological basis for antiangiogenic therapy.
    Giavazzi R; Albini A; Bussolino F; DeBraud F; Presta M; Ziche M; Costa A
    Eur J Cancer; 2000 Oct; 36(15):1913-8. PubMed ID: 11000570
    [No Abstract]   [Full Text] [Related]  

  • 53. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 54. Angiostatic proteins and peptides.
    Bouma-ter Steege JC; Mayo KH; Griffioen AW
    Crit Rev Eukaryot Gene Expr; 2001; 11(4):319-34. PubMed ID: 12067070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence of efficacy: researchers investigating markers for angiogenesis inhibitors.
    Brower V
    J Natl Cancer Inst; 2003 Oct; 95(19):1425-7. PubMed ID: 14519742
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular mechanisms of tumor angiogenesis and tumor progression.
    Cavallaro U; Christofori G
    J Neurooncol; 2000; 50(1-2):63-70. PubMed ID: 11245282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adipose tissue mass can be regulated through the vasculature.
    Rupnick MA; Panigrahy D; Zhang CY; Dallabrida SM; Lowell BB; Langer R; Folkman MJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10730-5. PubMed ID: 12149466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.
    Yazaki T; Takamiya Y; Costello PC; Mineta T; Menon AG; Rabkin SD; Martuza RL
    J Neurooncol; 1995; 23(1):23-9. PubMed ID: 7542695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical perspective of angiogenesis inhibitors].
    Radema SA; Witteveen PO; Gebbink MB; Voest EE
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.